Promising trial for Alzheimer's treatment

Eli Lilly last week announced the results of a Phase 3 trial on its experimental drug called Donanemab. The latest drug trial in a new class of Alzheimer’s drugs gives researchers and advocates renewed hope of slowing the progression of the brain disease.

FOX 9 is your source for breaking news, live events, investigations, politics, entertainment, business news and local stories from Minneapolis-St. Paul, the greater Twin Cities metro, Greater Minnesota, western Wisconsin and across the nation. FOX 9 is the Official Home of the Minnesota Vikings and proud partner of University of Minnesota Golden Gophers Athletics.

Download the Weather app